These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27150493)

  • 1. Anchoring in Destination-Therapy Left Ventricular Assist Device Decision Making: A Mechanical Turk Survey.
    Paine AM; Allen LA; Thompson JS; McIlvennan CK; Jenkins A; Hammes A; Kroehl M; Matlock DD
    J Card Fail; 2016 Nov; 22(11):908-912. PubMed ID: 27150493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caregivers of Patients Considering a Destination Therapy Left Ventricular Assist Device and a Shared Decision-Making Intervention: The DECIDE-LVAD Trial.
    McIlvennan CK; Matlock DD; Thompson JS; Dunlay SM; Blue L; LaRue SJ; Lewis EF; Patel CB; Fairclough DL; Leister EC; Swetz KM; Baldridge V; Walsh MN; Allen LA
    JACC Heart Fail; 2018 Nov; 6(11):904-913. PubMed ID: 30316931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of an Intervention Supporting Shared Decision Making for Destination Therapy Left Ventricular Assist Device: The DECIDE-LVAD Randomized Clinical Trial.
    Allen LA; McIlvennan CK; Thompson JS; Dunlay SM; LaRue SJ; Lewis EF; Patel CB; Blue L; Fairclough DL; Leister EC; Glasgow RE; Cleveland JC; Phillips C; Baldridge V; Walsh MN; Matlock DD
    JAMA Intern Med; 2018 Apr; 178(4):520-529. PubMed ID: 29482225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices.
    John R; Naka Y; Park SJ; Sai-Sudhakar C; Salerno C; Sundareswaran KS; Farrar DJ; Milano CA
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):581-9; discussion 589. PubMed ID: 24418362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidities and the decision to undergo or forego destination therapy left ventricular assist device implantation: An analysis from the Trial of a Shared Decision Support Intervention for Patients and their Caregivers Offered Destination Therapy for End-Stage Heart Failure (DECIDE-LVAD) study.
    Warraich HJ; Allen LA; Blue LJ; Chaussee EL; Thompson JS; McIlvennan CK; Flint KM; Matlock DD; Patel CB
    Am Heart J; 2019 Jul; 213():91-96. PubMed ID: 31129442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of cardiac computed tomography for inflow cannula patency assessment and prediction of clinical outcome in patients with the HeartMate II left ventricular assist device.
    Sacks J; Gonzalez-Stawinski GV; Hall S; Lima B; MacHannaford J; Dockery W; Cura M; Chamogeorgakis T
    Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):590-3. PubMed ID: 26223857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular assist device in patients with body mass index greater than 30 as bridge to weight loss and heart transplant candidacy.
    Yanagida R; Czer LS; Mirocha J; Rafiei M; Esmailian F; Moriguchi J; Kobashigawa JA; Trento A
    Transplant Proc; 2014 Dec; 46(10):3575-9. PubMed ID: 25498092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Decision Aid for Patients With Advanced Heart Failure Considering a Destination Therapy Left Ventricular Assist Device.
    Thompson JS; Matlock DD; McIlvennan CK; Jenkins AR; Allen LA
    JACC Heart Fail; 2015 Dec; 3(12):965-76. PubMed ID: 26671675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with the HeartMate II Left Ventricular Assist Device in Patients Older than 60 Years.
    Demirozu ZT; Critsinelis A; Cohn WE; Radovancevic R; Ho J; Hernandez R; Morgan JA; Frazier OH
    Heart Surg Forum; 2019 Mar; 22(2):E124-E130. PubMed ID: 31013222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Multicenter Trial of a Shared Decision Support Intervention for Patients and Their Caregivers Offered Destination Therapy for Advanced Heart Failure: DECIDE-LVAD: Rationale, Design, and Pilot Data.
    McIlvennan CK; Thompson JS; Matlock DD; Cleveland JC; Dunlay SM; LaRue SJ; Lewis EF; Patel CB; Walsh MN; Allen LA
    J Cardiovasc Nurs; 2016; 31(6):E8-E20. PubMed ID: 27203272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study.
    Long JW; Kfoury AG; Slaughter MS; Silver M; Milano C; Rogers J; Delgado R; Frazier OH
    Congest Heart Fail; 2005; 11(3):133-8. PubMed ID: 15947534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved durability of the HeartMate XVE left ventricular assist device provides safe mechanical support up to 1 year but is associated with high risk of device failure in the second year.
    Martin J; Friesewinkel O; Benk C; Sorg S; Schultz S; Beyersdorf F
    J Heart Lung Transplant; 2006 Apr; 25(4):384-90. PubMed ID: 16563965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring cognitive bias in destination therapy left ventricular assist device decision making: A retrospective qualitative framework analysis.
    Magid M; McIlvennan CK; Jones J; Nowels CT; Allen LA; Thompson JS; Matlock D
    Am Heart J; 2016 Oct; 180():64-73. PubMed ID: 27659884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential impact on post-transplant outcomes between pulsatile- and continuous-flow left ventricular assist devices.
    Ventura PA; Alharethi R; Budge D; Reid BB; Horne BD; Mason NO; Stoker S; Caine WT; Rasmusson B; Doty J; Clayson SE; Kfoury AG
    Clin Transplant; 2011; 25(4):E390-5. PubMed ID: 21401721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.
    Kamdar F; Boyle A; Liao K; Colvin-adams M; Joyce L; John R
    J Heart Lung Transplant; 2009 Apr; 28(4):352-9. PubMed ID: 19332262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.